What Researchers Study This Peptide For
Published research has examined this peptide in laboratory, animal and, where available, human studies involving the following areas:
Evidence represented: Laboratory • Animal • Limited human
- Mitochondrial signalingMechanistic
- Cellular energy regulationLaboratory
- Glucose-metabolism researchLaboratory and animal
- Insulin-signaling pathwaysLaboratory and animal
- Exercise-response modelsAnimal and limited human
- Age-related metabolic researchLaboratory and animal
These topics describe areas of scientific investigation. Findings vary by study design, research model, formulation and evidence quality and should not be interpreted as established human outcomes.
What should you know first?
What Is MOTS-c?
MOTS-c is a short mitochondrial-derived peptide associated with a 16-amino-acid sequence encoded by a small open reading frame within mitochondrial genetic material.
Mitochondria help manage cellular energy production and signaling. MOTS-c research examines how mitochondrial signals may communicate with the rest of a cell.
Ryse records verify a MOTS-c 10 mg listing, label, and bundled COA, but do not clearly identify free base, acetate, or another form. This page therefore assigns no chemical form, sequence, formula, molecular weight, or CAS number to the catalog material.
What Does Mitochondrial-Derived Mean?
A mitochondrial-derived peptide is a short amino-acid chain associated with genetic information inside mitochondria rather than the cell nucleus.
Researchers study these peptides to understand communication involving mitochondria, stress responses, metabolic signaling, gene activity, and changing cellular conditions.
Areas of MOTS-c Research
Published experimental work has explored MOTS-c in laboratory and animal models involving mitochondrial communication and cellular responses. These research areas do not establish approved uses or proven human outcomes.
Studies examine possible signals outside mitochondria involving energy sensing, stress responses, gene activity, and glucose-related pathways. These are investigated mechanisms, not established treatment mechanisms.
- Mitochondrial signaling
- Cellular stress responses
- Metabolic regulation and glucose-related laboratory models
- Skeletal-muscle and cellular energy-sensing models
- Gene-expression responses and mitochondria-to-nucleus communication
- Aging-related and exercise-related laboratory or animal models
- Analytical identification, stability, and peptide characterization
What should you know first?
Current evidence classification: primarily preclinical. Most findings come from cell studies, laboratory models, animal studies, or observational measurements of naturally occurring MOTS-c.
These designs form hypotheses but cannot establish human safety, effectiveness, dosing, routes, long-term effects, FDA approval, or a recognized medical use.
Human information is very limited. Measuring naturally occurring MOTS-c is different from administering a product and does not establish product safety or effectiveness.
What are the limits of the current evidence?
MOTS-c research does not currently establish human safety, effectiveness, or suitability for personal use.
- Most research is preclinical, and animal findings cannot automatically be applied to humans.
- Observing naturally occurring MOTS-c does not establish the safety of an administered product.
- Laboratory findings do not establish a treatment benefit.
- Human dosing and long-term safety have not been established.
- Different product forms may not be chemically identical.
- Product quality can vary between suppliers and batches.
- A scientific paper does not verify a specific commercial product.
- MOTS-c is not FDA approved as a drug.
Product Identity and COA Documentation
The name MOTS-c alone does not establish form, sequence, identity, purity, concentration, stability, sterility, endotoxin status, or experimental suitability.
Match the product, form, batch or lot, sample ID, molecular description, analytical results, methods, laboratory, dates, and limitations.
Purity estimates relative composition under a stated method; identity evaluates consistency with the expected peptide. Neither establishes human safety, sterility, or unreported attributes.
- Does the batch number match the product?
- Does the report identify the tested form?
- Are expected and observed masses or another molecular description shown?
- Are the analytical method, chromatographic data, laboratory, and test date identified?
- Does the document distinguish identity from purity and explain test limitations?
How should laboratories approach storage and handling?
Follow verified product-specific storage documentation and institutional laboratory procedures for the exact material and form.
Verified form-specific stability support for a storage temperature was not found, so none is assigned. No preparation, solvent, route, dose, or personal-use instructions are provided.
- Confirm whether the material is free base, acetate, or another form.
- Maintain accurate product and batch identification.
- Record storage conditions, duration, transfers, and excursions.
- Protect material from inappropriate heat, moisture, or light where specified.
- Review stability information for the exact product form.
- Follow institutional handling and applicable laboratory-disposal procedures.
What is its regulatory status?
MOTS-c is not FDA approved as a drug and appears on the current World Anti-Doping Agency Prohibited List. Research Use Only labeling does not make it permissible for tested athletes.
FDA reports limited human exposure and safety information and discusses possible immunogenicity, impurities, aggregation, and characterization concerns.
At its July 2026 advisory-committee meeting, FDA proposed that MOTS-c free base and acetate not be added to the 503A Bulks List. This was a proposal, not a final approval decision.
Frequently Asked Questions
What is MOTS-c?
A mitochondrial-derived peptide described as a 16-amino-acid sequence associated with mitochondrial genetic material.
What does MOTS-c stand for?
MOTS-c stands for mitochondrial open reading frame of the 12S rRNA type-c.
Why is MOTS-c called a mitochondrial-derived peptide?
Its reported sequence is associated with genetic information inside mitochondria.
How many amino acids are in MOTS-c?
The scientific literature describes MOTS-c as containing 16 amino acids.
What areas of MOTS-c research are being studied?
Mitochondrial signaling, stress responses, metabolic models, gene activity, and analytical characterization.
Are most MOTS-c studies conducted in humans?
No. Most evidence comes from laboratory and animal research; human information is very limited.
Does research on naturally occurring MOTS-c prove that MOTS-c products are safe?
No. Measuring a natural peptide is not a product-administration study and cannot establish product safety.
Is MOTS-c FDA approved?
No. MOTS-c is not FDA approved as a drug.
Is MOTS-c intended for human consumption?
No. Ryse products are for legitimate laboratory research, not human or veterinary consumption.
Is MOTS-c prohibited in tested sports?
Yes. MOTS-c appears on the current WADA Prohibited List. Research labeling does not alter anti-doping rules.
What does a MOTS-c COA show?
Identifiers, methods, dates, and results for a defined sample and stated tests.
What is the difference between identity and purity?
Identity evaluates compound consistency; purity estimates relative composition under a stated method.
Does a COA prove a product is safe?
No. It reports stated tests, not general safety, approval, or untested attributes.
Is this page medical advice?
No. It provides general research-literacy education and no medical or personal-use guidance.
Selected MOTS-c Studies
External publications are provided for scientific-literacy purposes. Inclusion does not establish product equivalence, human safety, effectiveness, regulatory approval or suitability for personal use.
The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
The original 2015 laboratory and animal publication identifying a 16-amino-acid mitochondrial-derived peptide. Its model findings do not establish human outcomes.
Mitochondrially derived peptides as novel regulators of metabolism
A peer-reviewed overview of mitochondrial-derived peptide biology and the early evidence base, which remains centered on experimental models.
FDA briefing document: MOTS-c-related bulk drug substances
FDA's 2026 safety and regulatory evaluation of nominated MOTS-c free-base and acetate substances; it is not evidence of approval.
Research Use Only
Information on this page is provided solely for general scientific education and laboratory-research literacy. It is not medical advice and does not provide dosing, reconstitution, administration or personal-use guidance.
Ryse Peptides products are intended only for legitimate laboratory research where legally permitted. They are not intended for human or veterinary consumption and are not intended to diagnose, treat, cure, mitigate or prevent any disease.
MOTS-c is not approved by the U.S. Food and Drug Administration as a drug. Published laboratory, animal and observational findings should not be interpreted as evidence of established human safety, effectiveness or clinical usefulness.